ENvue Medical, Inc.
FEED
$1.16
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.20% | -18.41% | -30.66% | -6.60% | 12.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.20% | -18.41% | -30.66% | -6.60% | 12.05% |
| Cost of Revenue | 128.57% | 41.38% | 32.97% | 63.91% | 40.75% |
| Gross Profit | -89.85% | -58.92% | -65.56% | -38.30% | -1.89% |
| SG&A Expenses | 142.19% | 109.80% | 69.15% | 10.62% | -5.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 132.70% | 107.53% | 86.72% | 38.41% | 14.57% |
| Operating Income | -227.61% | -269.81% | -262.38% | -87.95% | -16.45% |
| Income Before Tax | -418.58% | -137.43% | -215.66% | -76.29% | -0.11% |
| Income Tax Expenses | -1,715.79% | 368.00% | 240.00% | -20.59% | -34.48% |
| Earnings from Continuing Operations | -407.64% | -139.29% | -215.87% | -75.27% | 0.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -407.64% | -139.29% | -215.87% | -75.27% | 0.16% |
| EBIT | -227.61% | -269.81% | -262.38% | -87.95% | -16.45% |
| EBITDA | -202.63% | -244.89% | -245.54% | -87.25% | -16.47% |
| EPS Basic | 41.33% | 20.50% | 42.50% | 42.02% | 60.90% |
| Normalized Basic EPS | 45.62% | -8.53% | 26.16% | 34.00% | 57.16% |
| EPS Diluted | 41.33% | 20.50% | 42.50% | 42.02% | 60.90% |
| Normalized Diluted EPS | 45.62% | -8.53% | 26.16% | 34.00% | 57.16% |
| Average Basic Shares Outstanding | 580.85% | 314.56% | 936.41% | 454.02% | 478.93% |
| Average Diluted Shares Outstanding | 580.85% | 314.56% | 936.41% | 454.02% | 478.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |